Сандиммун
(Cyclosporin A)
(100 mg)
(fifty)
(Tablets)
Equoral (Cyclosporin A) 100 mg 50 tabs TEVA Israel
Article:
In Stock
Interchangeable drugs with the same active ingredient:
- Imusporin-100
- Imusporin-50
- lifemoon
- Neolem
- Panimun Bioral
- Restasis
- Sandimmun
- Sandimmun Neoral
- Cyclosporine Alkaloid
- Equoral
Indications:
Indications for transplants
Solid Organ Transplantation:
- Prevention of rejection of solid organ transplants;
- Treatment of transplant rejection in patients previously treated with other immunosuppressive drugs.
Bone marrow transplant:
- Prevention of rejection of allogeneic bone marrow transplant and stem cell transplant;
- Prevention and treatment of graft-versus-host disease.
Non-transplant indications
Endogenous uveitis:
- Active medial or posterior uveitis threatening visual loss, non-infectious etiology, in cases where alternative treatment has been ineffective or unacceptable due to adverse reactions;
- Uveitis in Behcet's disease with repeated exacerbations of inflammation involving the retina without neurological symptoms.
Nephrotic Syndrome:
- Steroid-dependent or steroid-resistant nephrotic syndrome due to minimal changes in glomerulonephritis, focal glomerulosclerosis or membranous glomerulonephritis,
- Induction or maintenance of remission
- Maintenance of remission caused by corticosteroids, which makes them cancelled.
Rheumatoid arthritis:
- Treatment of severe forms of active rheumatoid arthritis.
Psoriasis:
- Severe forms of psoriasis where standard treatment has failed or is unacceptable.
Atopic dermatitis:
- treatment of severe forms of atopic dermatitis, if necessary, systemic therapy.
- ikvoral, ekvoral, tsiklasporin, tsiklasparin, evoral, evoral, ivoral, 506815716;9;
-
Commercial name:Сандиммун
-
Сhemical name:Cyclosporin A
-
Dosage:100 mg
-
Quantity:fifty
-
Release form:Tablets
-
Виробник:Новартис
No reviews yet